M-min 850 mg (Tablet)

Unit Price: ৳ 4.51 (3 x 10: ৳ 135.30)
Strip Price: ৳ 45.10

Medicine Details

Indications

  • Treatment of type 2 diabetes mellitus
  • Management of type 2 diabetes in overweight patients

Pharmacology

  • Biguanide type oral antihyperglycemic drug
  • Lowers basal and postprandial plasma glucose
  • Different mechanism of action from sulfonylureas
  • Does not produce hypoglycemia
  • Decreases hepatic glucose production
  • Decreases intestinal absorption of glucose
  • Improves insulin sensitivity

Dosage & Administration

  • Individualized dosage based on effectiveness and tolerance
  • Usual starting dose of 500mg or 850mg
  • Dosage increases in increments of 500mg or 850mg
  • Maximum daily doses of 2000mg or 2550mg
  • Instruction for immediate release tablet and extended release tablet consumption
  • Specific dosage advice for children
  • Dosage adjustment for renal impaired patients

Interaction

  • Interactions with Furosemide and Nifedipine
  • Potential interaction with cationic drugs eliminated by renal tubular secretion
  • Minimal effect on Cimetidine pharmacokinetics
  • List of drugs leading to loss of glycemic control

Contraindications

  • Hypersensitivity to active substance or excipients
  • Acute metabolic acidosis
  • Severe renal failure
  • Acute conditions altering renal function
  • Conditions causing tissue hypoxia

Side Effects

  • Rare side effects related to blood and lymphatic system disorders
  • Very rare side effects related to metabolism and nutrition disorders
  • Common and rare nervous system disorders
  • Very common gastrointestinal disorders
  • Very rare hepatobiliary disorders
  • Very rare skin and subcutaneous tissue disorders

Pregnancy & Lactation

  • Increased risk of congenital abnormalities and perinatal mortality with uncontrolled diabetes during pregnancy
  • Recommendation to use insulin instead of metformin during pregnancy
  • Presence of metformin in human breast milk
  • Limited data on adverse effects on breastfed newborns/infants
  • Caution and recommendations about breastfeeding during metformin treatment

Precautions & Warnings

  • Excretion by the kidney and risk of accumulation and lactic acidosis
  • Lowering of vitamin B12 levels
  • Increased risk of hypoglycemia when used in combination with insulin
  • Recommendation for regular monitoring of renal function
  • Advice to stop therapy before surgery and reinstate after renal function recovery
  • Not advised in conditions causing dehydration or serious infections or trauma
  • Annual estimation of Vitamin B-12 levels for patients on continuous therapy
  • Possible interaction with anticoagulants

Use in Special Populations

  • Need for adjusted dosage in elderly subjects based on renal function
  • No effect on growth and puberty detected during controlled clinical studies
  • Recommended follow-up of metformin effect on growth and puberty in children
  • Particular caution recommended when prescribing to children aged between 10 and 12 years
  • Regular assessment of renal function before and during treatment

Overdose Effects

  • Absence of hypoglycemia at high doses
  • Occurrence of lactic acidosis
  • Treatment method for lactic acidosis

Therapeutic Class

  • Biguanides

Storage Conditions

  • Temperature and protection instructions

Related Brands